In view of the positive association between increased NAP1 expression levels and tumor progression identified in these studies, caution should be taken in the effort of developing therapeutic interventions based on NAP1 regulatory strategies for both breast and lung cancer. The gene discussed is NCKAP1; the disease is lung carcinoma.